“…A potent, selective, and orally active inhibitor of neutrophil elastase is believed to inhibit the progression of the long-term lung function decline in COPD patients by inhibition of neutrophilinduced upregulation of pro-inflammatory chemokines, such as interleukin-8, and by inhibition of elastase-mediated lung tissue destruction. 2,6,[10][11][12][13][14] In addition to COPD, HNE is associated with several severe medical conditions, for example, cystic fibrosis, 15,16 ischemia reperfusion injury, 17 and acute respiratory distress syntrome, 18,19 and has been found to promote tumor development and metastasis. 20,21 Despite of its high medicinal relevance and many biochemically characterized inhibitors, 13,22,23 only a limited number of crystal structures of HNE have been published.…”